Literature DB >> 18675759

Relaxin family peptide receptors--from orphans to therapeutic targets.

Emma T van der Westhuizen1, Michelle L Halls, Chrishan S Samuel, Ross A D Bathgate, Elaine N Unemori, Steven W Sutton, Roger J Summers.   

Abstract

The relaxin family peptides have distinct expression profiles and physiological functions. Several of them are the cognate ligands for 4 G-protein-coupled relaxin family peptide receptors (RXFPs; formerly LGR7, LGR8, GPCR135, GPCR142). The relaxin/RXFP1 system has roles in reproductive physiology but is also involved in fibrosis, wound healing and responses to infarction. Relaxin has a potential use in congestive heart failure where fibrosis plays an important role in organ failure. The INSL3/RXFP2 system has biological roles in reproductive biology that may have limited therapeutic potential. However, the recently characterized relaxin-3/RXFP3 system is important in stress/anxiety and body composition. RXFP3 receptor antagonists are potentially novel anti-anxiety and anti-obesity drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675759     DOI: 10.1016/j.drudis.2008.04.002

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  18 in total

1.  Neuronal modulation of the immune response.

Authors:  Dipankae Nandi; Manoj Bhosale
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

2.  Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro.

Authors:  C Zhang; D V Baimoukhametova; C M Smith; J S Bains; Andrew L Gundlach
Journal:  Psychopharmacology (Berl)       Date:  2017-03-17       Impact factor: 4.530

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.

Authors:  Alessia Frati; Barbara Ricci; Federica Pierucci; Silvia Nistri; Daniele Bani; Elisabetta Meacci
Journal:  Mol Endocrinol       Date:  2015-01

Review 5.  Relaxin: review of biology and potential role in treating heart failure.

Authors:  Sam L Teichman; Elaine Unemori; John R Teerlink; Gad Cotter; Marco Metra
Journal:  Curr Heart Fail Rep       Date:  2010-06

6.  Sub-picomolar relaxin signalling by a pre-assembled RXFP1, AKAP79, AC2, beta-arrestin 2, PDE4D3 complex.

Authors:  Michelle L Halls; Dermot M F Cooper
Journal:  EMBO J       Date:  2010-07-27       Impact factor: 11.598

7.  Transcriptional up-regulation of relaxin-3 by Nur77 attenuates β-adrenergic agonist-induced apoptosis in cardiomyocytes.

Authors:  Xiaohua You; Zhi-Fu Guo; Fang Cheng; Bing Yi; Fan Yang; Xinzhu Liu; Ni Zhu; Xianxian Zhao; Guijun Yan; Xin-Liang Ma; Jianxin Sun
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

Review 8.  Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity.

Authors:  C K Boughton; K G Murphy
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

9.  Trends in serum relaxin concentration among elite collegiate female athletes.

Authors:  Jason L Dragoo; Tiffany N Castillo; Tatiana A Korotkova; Ashleigh C Kennedy; Hyeon Joo Kim; Dennis R Stewart
Journal:  Int J Womens Health       Date:  2011-01-19

10.  In vitro effects of relaxin on gene expression in porcine cumulus-oocyte complexes and developing embryos.

Authors:  Jean M Feugang; Jonathan M Greene; Scott T Willard; Peter L Ryan
Journal:  Reprod Biol Endocrinol       Date:  2011-01-27       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.